Advertisement

Topics

Q-BIO gene Company Profile

17:40 EST 10th December 2018 | BioPortfolio

Our roots go back more than 40 years to when Milan Panic founded ICN Pharmaceuticals in 1959 from the basement of his Pasadena home. Mr. Panic used his strategic vision to expand from California into Russia and China, placing ICN in a position to take advantage of the emerging world economy in the new millennium.In 2002, Mr. Panic stepped down as chairman and chief executive officer of ICN Pharmaceuticals and purchased MP Biomedicals. This experience, coupled with his acquisition of MP Biomedicals makes possible a new age of discovery in the life science and biotechnology industries.Today, the company manufactures and sells more than 55,000 products and is one of the only companies in the industry to offer a comprehensive line of life science, fine chemical and diagnostic products.MP Biomedicals is a world-wide corporation, with its headquarters located in Irvine, California and satellite offices in Europe, Asia and Australia. We also maintain a vast network of global distributors, including our ISO 9002 diagnostic products facility in Orangeburg, New York, and distribution centers in Aurora, Ohio and Burlingame, California.No matter how dynamic the evolution of the life science and biotechnology markets, we remain committed to supporting our customers in their efforts to make new discoveries. From basic research, through scale-up, to full-scale production and diagnostic testing, MP Biomedicals serves every industry need – from specialized areas of research to supplying large scale quantities of fine chemicals.

Location

15 Morgan
Irvine
California
92618-2005
United States of America

Contact

Phone: (800) 854-0530
Fax: 800-334-6999
Email: info@qbiogene.com


News Articles [1274 Associated News Articles listed on BioPortfolio]

Co-evolution between a 'parasite gene' and its host

(Aarhus University) A Danish research team has delineated a complex symbiosis between a 'parasitic' noncoding RNA gene and its protein coding 'host' gene in human cells. The study reveals how co-evolu...

CRISPR-Cas9 Used to Retain Function of Mutated Growth Gene in Tomato

PROCERA is a gene involved in growth regulation in tomato. Destructing the proteins made from this gene induces growth. In a previous study, this gene was edited to lose its function in tomato so that...

DNA Enhancer Video Rules Out Hit-and-Run Activity

After a segment of non-protein – coding DNA called an enhancer gets close to its target gene, it tends to stick around, staying attached to the gene’s promoter while the gene’s transcription pro...

Precise, Highly Efficient Gene Repair

The molecular tool CRISPR/Cas allows introducing DNA double strand breaks into any gene of interest consequently resulting in stochastic mutations at the site of the target gene. However, precise gen...

American Gene Technologies: the first bio-safe gene delivery vector for human clinical therapeutic use

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with Jeff Galvin, Chief Executive Officer at American Gene Technologies, a genetic research firm focusing on gene therap...

Gene Therapy Shows Promise for Ending Hemophilia, With Some Long-Term Concerns

Gene therapy has been a dream for many researchers for decades—inserting a healthier gene into patients’ cells to replace defective genes and curing diseases. One disease that would seem to be a g...

Gene-edited Rice Shows BIG Gene Vital for Seedling Viability

Arabidopsis BIG (AtBIG) gene encodes a large protein necessary for auxin transport and when turned off leads to changes in plant structure and adaptability to environmental stimuli. A similar gene (Os...

Scientists Wipe Out a Mosquito Population Through Genome-editing

Scientist Andrea Crisanti from Imperial College London in the United Kingdom and colleagues edit the doublesex gene in the mosquito malaria vector Anopheles gambiae using CRISPR-Cas9. Through the disr...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

R-gene [Pharmacia and Upjohn Company]

R-Gene 10Arginine Hydrochloride Injection, USP

Retin-a micro [Ortho-McNeil Pharmaceuticals]

RETIN-A MICRO® (tretinoin gel) microsphere, 0.1% and 0.04%

Retin-a micro [Physicians Total Care, Inc.]

RETIN-A MICRO® (tretinoin gel) microsphere, 0.1% and 0.04%

PubMed Articles [1685 Associated PubMed Articles listed on BioPortfolio]

Polycations for Gene Delivery: Dilemmas and Solutions.

Gene therapy has been a promising strategy for treating numerous gene-associated human diseases by altering specific gene expressions in pathological cells. Application of non-viral gene delivery is h...

The mcr-1 Gene Has No Effect on Colistin Resistance When It Coexists with Inactivated mgrB Gene in Klebsiella pneumoniae.

The inactivated mgrB gene and the mcr-1 gene are important mechanisms of colistin resistance in Klebsiella pneumoniae and they are threats to the clinical use of colistin. In this study, mcr-1 gene wa...

Compositional properties and codon usage of TP73 gene family.

The TP73 gene is considered as one of the members of TP53 gene family and shows much homology to p53 gene. TP73 gene plays a pivotal role in cancer studies in addition to other biological functions. C...

Genetic diagnosis for X-linked hypohidrotic ectodermal dysplasia family with a novel Ectodysplasin A gene mutation.

To make a gene diagnosis for a family with Ectodysplasin A (EDA) gene mutation as well as prenatal diagnosis, and report a novel EDA gene mutation.

CHANGES IN RETINAL SENSITIVITY AFTER GENE THERAPY IN CHOROIDEREMIA.

Choroideremia (CHM) is a rare inherited retinal degeneration resulting from mutation of the CHM gene, which results in absence of functional Rab escort protein 1 (REP1). We evaluated retinal gene ther...

Clinical Trials [1915 Associated Clinical Trials listed on BioPortfolio]

Genomic Structural Variation in Cancer Susceptibility

This study will look for new types of gene changes that may be related to cancer in some patients. Some gene changes (mutations) are passed on from parents to offspring (child). Other gene...

Lentiviral Gene Therapy for X-ALD

This is a Phase I/II clinical trial of gene therapy for treating X-linked adrenoleukodystrophy using a high-safety, high-efficiency, self-inactivating lentiviral vector TYF-ABCD1 to functi...

Gene Therapy in Treating Patients With Cancer of The Liver

RATIONALE: Inserting the p53 gene into a person's tumor may improve the body's ability to fight liver cancer. PURPOSE: Phase I trial to study the effectiveness of gene therapy with the p5...

Phase I Study of Ex Vivo Liver-Directed Gene Therapy for Familial Hypercholesterolemia

OBJECTIVES: I. Develop an approach for treating patients with homozygous familial hypercholesterolemia using gene therapy with autologous hepatocytes transduced with a normal low-density...

Gene Therapy of Beta Thalathemia Using a Self-inactivating Lentiviral Vector

This is a Phase I/II clinical trial of gene transfer for treating Beta-thalassemia using a self-inactivating lentiviral vector to functionally correct the defective gene(s). The objectives...

Companies [535 Associated Companies listed on BioPortfolio]

Gene Therapy Systems (GTS)

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is ...

PhenomicDB

PhenomicDB is a multi-organism phenotype-genotype database including human, mouse, fruit fly, C.elegans, and other model organisms. The inclusion of gene indeces (NCBI Gene) and orthologues (same gene...

Gene Smart

Gene Smart Wellness is a preventative healthcare company dedicated to pioneering real world approaches that empower individuals to take control of their whole health in order to live abundantly. The c...

Sequitur Incorporated

Sequitur, Inc. was founded in 1996 to develop innovative sequence-based compounds for functional genomics research, diagnostic and therapeutic applications. Sequitur's proprietary antisense technolo...

RheoGene Inc

RheoGene is developing the RheoSwitch® Therapeutic System (RTS) for cell and gene therapy. RTS delivers therapeutic gene products in the patient to the right place, at the right time, and at the righ...

More Information about "Q-BIO gene" on BioPortfolio

We have published hundreds of Q-BIO gene news stories on BioPortfolio along with dozens of Q-BIO gene Clinical Trials and PubMed Articles about Q-BIO gene for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Q-BIO gene Companies in our database. You can also find out about relevant Q-BIO gene Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record